- Home
- PCTY vs APGE Comparison
PCTY vs APGE Comparison
Compare PCTY & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PCTY | APGE |
|---|---|---|
| Founded | 1997 | 2022 |
| Country | United States | United States |
| Employees | 6700 | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 5.0B |
| IPO Year | 2014 | 2023 |
Fundamental Metrics
Financial Performance| Metric | PCTY | APGE |
|---|---|---|
| Price | $111.02 | $68.50 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 17 | 11 |
| Target Price | ★ $180.24 | $101.20 |
| AVG Volume (30 Days) | 640.4K | ★ 690.5K |
| Earning Date | 04-30-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.74 | N/A |
| EPS | ★ 1.77 | N/A |
| Revenue | ★ $1,595,221,000.00 | N/A |
| Revenue This Year | $11.14 | N/A |
| Revenue Next Year | $8.01 | N/A |
| P/E Ratio | $62.05 | ★ N/A |
| Revenue Growth | ★ 13.74 | N/A |
| 52 Week Low | $100.90 | $26.20 |
| 52 Week High | $201.97 | $84.56 |
Technical Indicators
Market Signals| Indicator | PCTY | APGE |
|---|---|---|
| Relative Strength Index (RSI) | 44.31 | 44.72 |
| Support Level | $101.15 | $66.00 |
| Resistance Level | $119.87 | $71.18 |
| Average True Range (ATR) | 4.07 | 3.83 |
| MACD | 0.74 | -0.44 |
| Stochastic Oscillator | 38.76 | 22.17 |
Price Performance
Historical ComparisonAbout PCTY Paylocity Holding Corporation
Founded in 1997, Paylocity is a cloud-based human capital management and payroll platform servicing midmarket customers. The company's average client size is around 150 employees. Its products help with recruiting and onboarding, payroll, time and labor, human resources, benefits, learning, and performance and compensation workflows. In fiscal 2025, the company generated over $1.5 billion in revenue across more than 41,000 customers.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.